COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,026 Articles (22,627 medRxiv, 8,399 bioRxiv)

Most recent first Previous |  Page 107: Articles 1061-1070  | Next

Changing parental perceptions to childhood immunisations during the Covid-19 pandemic in the UK: evidence from three cross-sectional surveys between 2020 and 2022
Thistlethwayte, R., de Figueiredo, A.
10.1101/2024.11.29.24318181 — Posted: 2024-12-05
Genome-wide Machine Learning Analysis of Anosmia and Ageusia with COVID-19
Pietan, L., Phillippi, E., Melo, M., El-Shanti, H., Smith, B. J., Darbro, B., Braun, T., Casavant, T.
10.1101/2024.12.04.24318493 — Posted: 2024-12-05
Ubiquitin Ligase ITCH Regulates Life Cycle of SARS-CoV-2 Virus
Xiang, Q., Wouters, C., Chang, P., Lu, Y.-N., Liu, M., Wang, H., Yang, J., Pekosz, A., Zhang, Y., Wang, J.
10.1101/2024.12.04.624804 — Posted: 2024-12-05
Optimizing a Human Monoclonal Antibody for Better Neutralization of SARS-CoV-2
Wang, Q., Guo, Y., Casner, R. G., Yu, J., Nair, M. S., Ho, J., Reddem, E. R., Tzang, C. C., Huang, Y., Shapiro, L., Liu, L., Ho, D. D.
10.1101/2024.12.04.626800 — Posted: 2024-12-05
Intra-familial dynamics of mental distress during the Covid-19 lockdown
Pettersen, J. H., Eilertsen, E. M., Hegemann, L. E., Hannigan, L. J., Lund, I. O., Johannessen, P. M., Corfield, E. C., Ystrom, E., Andreassen, O., Havdahl, A., Brandlistuen, R. E., Ask, H.
10.1101/2024.12.04.24318462 — Posted: 2024-12-05
Optimal intervention strategies for a new pandemic: The case of Covid-19
Holden, S., Ro, G., Hjort, I.
10.1101/2024.12.04.24318460 — Posted: 2024-12-05
Widespread gene-environment interactions shape the immune response to SARS-CoV-2 infection in hospitalized COVID-19 patients
Randolph, H. E., Aguirre-Gamboa, R., Brunet-Ratnasingham, E., Nakanishi, T., Locher, V., Ketter, E., Brandolino, C., Larochelle, C., Prat, A., Arbour, N., Dumaine, A., Finzi, A., Durand, M., Richards, J. B., Kaufmann, D. E., Barreiro, L. B.
10.1101/2024.12.03.626676 — Posted: 2024-12-04
An accelerating, decreasing phylogenetic trend in SARS-CoV-2 genome compositional heterogeneity during the pandemic
Oliver, J. L., Bernaola Galvan, P., Carpena, P., Perfectti, F., Gomez Martin, C., Castiglione, S., Raia, P., Verdu, M., Moya, A.
10.1101/2024.12.03.625388 — Posted: 2024-12-04
Altered spike dynamics drives immune evasion of SARS-CoV-2
Ugurlu, H., Salminen, P., Yuan, M., Fagerlund, R., Mäkelä, A. R., Zusinaite, E., Kesti, T., Rissanen, I., Merits, A., Wilson, I. A., Saksela, K.
10.1101/2024.12.03.626570 — Posted: 2024-12-04
The mammalian SKI complex is a broad-spectrum antiviral drug target that upregulates cellular cholesterol to inhibit viral replication
Weston, S., Baracco, L., Taylor, L., Scott, A., Kumar, G., Shapiro, P., MacKerell, A. D., Frieman, M. B.
10.1101/2024.12.03.626536 — Posted: 2024-12-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).